Description
Colomicin (sodium colistimethate) powder for solution for injections 2000000 IU №10 vial
Composition:
Colistimethate sodium is the active ingredient in Colomicin. Each vial contains 2000000 IU of colistimethate sodium.
Mechanism of Action:
Colistimethate sodium disrupts the bacterial cell membrane, leading to cell death.
Pharmacological Properties:
Colomicin exhibits potent antibacterial properties, particularly against multidrug-resistant gram-negative bacteria.
Indications for Use:
Colomicin is indicated for the treatment of infections caused by susceptible strains of bacteria.
Contraindications:
Do not use Colomicin if the patient is allergic to colistimethate sodium or any other ingredients in the product.
Side Effects:
Common side effects may include nausea, vomiting, and allergic reactions. Consult a healthcare provider for a complete list of potential side effects.
Usage Instructions:
The recommended dosage of Colomicin should be determined by the healthcare provider based on the patient’s condition. It is typically administered by intravenous injection.
Benefits Compared to Analogues:
Colomicin is distinguished by its efficacy against multidrug-resistant bacteria, offering a crucial treatment option in challenging clinical scenarios.
Suitable Patient Groups:
Colomicin can be used in various patient groups, including children and the elderly, under appropriate medical supervision.
Storage Conditions and Shelf Life:
Store Colomicin as per the manufacturer’s instructions. Check the expiration date on the packaging and do not use expired products.
Packaging Description:
Each package of Colomicin contains 10 vials, each vial containing 2000000 IU of colistimethate sodium powder for solution for injections.
Clinical Evidence and Proven Effectiveness:
Colistimethate sodium has demonstrated efficacy in treating various bacterial infections, particularly multidrug-resistant gram-negative bacteria. Clinical studies have shown the safety and effectiveness of Colomicin in severe bacterial infections.
